Company Overview and News

 
Canadian Dividend All-Stars Expected To Announce Dividend Increases - Week Of April 23

3h seekingalpha
It’s been a slow month of April for dividend raises, and this is the first Canadian Dividend All-Star article in a few weeks. Fear not, as with earnings season ramping up, so too will the dividend raises. This week, there are thirteen Canadian Dividend All-Stars scheduled to report earnings. Of those, only one is expected to announce a raise. Before we look ahead, let’s take a look at the results from the past few weeks.
Upvote Downvote

 
Norway wealth fund backs AGM proposals at Imperial Oil, TransCanada, Boliden

2018-04-20 reuters
OSLO (Reuters) - Norway’s $1 trillion sovereign wealth fund, the world’s largest, will back key proposals at the annual general meetings next week of three companies in which it holds stakes, the fund announced on Friday.
Upvote Downvote

 
Alberta limiting oil shipments expected to harm more than just B.C.

2018-04-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
International Cobalt Acquires Two Additional Projects

2018-04-17 globenewswire
VANCOUVER, British Columbia, April 17, 2018 (GLOBE NEWSWIRE) -- International Cobalt Corp. (CSE:CO) (the “Company” or “International Cobalt”) is pleased to announce that its wholly owned subsidiary, American Cobalt Corp. (“American Cobalt”) has entered into two option agreements (the “Option Agreements”) with Supreme Metals Corp. to acquire up to an 80% interest in two cobalt projects which are comprised of the Foster Marshall Project and the Mount Thom Project (collectively known as the “FM Projects”).
Upvote Downvote

 
Hockey Night in Canada’s original TV pitchman turns 100

2018-04-15 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Military fort under Nova Scotia oil facility should be excavated, archeologist says

2018-04-13 cbc.ca
Fort Clarence, a military fort built more than 250 years ago, could be a "beautiful destination" for visitors to Dartmouth, N.S., a local archeologist says, except for one hitch — it's completely buried underground.
Upvote Downvote

 
These Integrated Energy Stocks Are Gaining this Week

2018-04-06 editors.aws.marketrealist
Continuing with the biggest movers in the energy sector, we’ll now look at the top gainers from the US integrated energy sector for the week starting April 2.
Upvote Downvote

 
[Press] Husky Energy Announces Chief Financial Officer Resignation

2018-04-06 oilvoice
Husky Energy (TSX:HSE) today announced that Jon McKenzie, Chief Financial Officer, has resigned and will be leaving the Company effective April 5, 2018.
Upvote Downvote

 
Climate change risk reporting becomes hot topic among investors

2018-04-05 cbc.ca
A year-long review of climate change risk disclosures to investors by large Canadian publicly-traded companies has found huge disparities in practices between corporations and industries.
Upvote Downvote

 
Husky CFO Resigns

2018-04-05 rigzone
Husky Energy announced Thursday that its chief financial officer, Jon McKenzie, has resigned and will be leaving the company effective April 5.
Upvote Downvote

 
PRESS DIGEST- Canada- April 4

2018-04-04 reuters
April 4 (Reuters) - The following are the top stories from select Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
Canada’s crude-by-rail terminals sit idle amid locomotive shortage as demand for oil grows

2018-03-27 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Canada's Crude-by-Rail Terminals Sit Idle as Oil Glut Grows - Bloomberg

2018-03-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
'Artificial magma' technology used to suppress Alberta oil and gas well leaks

2018-03-22 cbc.ca
New technologies employing brute force as well as artificial volcanic action are being developed to better seal thousands of inactive oil and gas wells in Canada that are leaking methane, a greenhouse gas with an outsized impact on global warming.
Upvote Downvote

 
Shareholder motions demand Imperial Oil transparency on water risk, lobbying

2018-03-21 cbc.ca
Shareholders of Imperial Oil Ltd. are being asked to support motions to force it to be more transparent about its water-related risks from pollution and climate change, as well as its lobbying activities and expenditures.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 453038408